Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2012
10/17/2012CN102727750A Pharmaceutical composition for benefiting Yang and detoxifying and preparation method and application thereof
10/17/2012CN102727744A Tea pigment capsule having effect of strengthening immunity and preparation method thereof
10/17/2012CN102727732A Traditional Chinese medicine composition for treating immunoiogical sterility and application of traditional Chinese medicine composition in preparing medicine for treating immunoiogical sterility
10/17/2012CN102727713A Use of Liuwei dihuang preparation in preparations of treatment drugs for treating patients after heart stent surgeries
10/17/2012CN102727690A Chinese medicinal snorted powder for preventing allergic rhinitis
10/17/2012CN102727676A Traditional Chinese herbal composition for treating allergic purpura as well as preparation method and application thereof
10/17/2012CN102727631A Immunostimulatory injection for livestock
10/17/2012CN102727558A Tripterygium Hypoglaucum Hutch root extract, and bi-layer extended release tablet and application thereof
10/17/2012CN102727535A Germination activation technique of ganoderma spores and extraction of active substances of ganoderma spores
10/17/2012CN102727530A Combination and application of probiotics and related prebiotics
10/17/2012CN102727485A Application of Inula lineariifolia lactone A in preparation of medicine for treating multiple sclerosis
10/17/2012CN102727429A Pidotimod injection with modified stability, and preparation method thereof
10/17/2012CN102284038B Pure Chinese medicinal capsules for treating urticaria
10/17/2012CN102178763B Medicament for treating anaphylactoid purpura
10/17/2012CN102166183B Immunologic stimulant oral syrup and preparation method thereof
10/17/2012CN101951956B Drug delivery system for administration of poorly water soluble pharmaceutically active substances
10/17/2012CN101919801B Solid effervescent mixture for oral absorption
10/17/2012CN101880324B Monoclonal antibody of anti-human SIRPalpha, cell strain, preparation method and application thereof
10/17/2012CN101851237B spiro compounds, method for preparing same and application thereof
10/17/2012CN101691405B Fusion antigen uses as vaccine
10/17/2012CN101676305B Low molecular weight glucan and preparation method and application thereof
10/17/2012CN101412692B 1-(3-amino propyl) piperidine-4-aminoamide compounds, and pharmaceutical composition, preparation and use thereof
10/17/2012CN101406452B Ciclosporin A microemulsion formulation for injection and preparation method thereof
10/17/2012CN101115772B Cytotoxic antibody directed against type-B lymphoid haematopoietic prolifeeations
10/16/2012US8288560 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
10/16/2012US8288539 Dipeptidyl peptidase inhibitors
10/16/2012US8288537 Caspase inhibitors and uses thereof
10/16/2012US8288368 inhibitors of the C5a induced chemotaxis; psoriasis, ulcerative cholitis, glomerular nephritis, acute respiratory insufficiency, idiopathic fibrosis, rheumatoid arthritis and in the prevention and the treatment of injury caused by ischemia and reperfusion
10/16/2012US8288139 Sulfotransferase inhibitors
10/16/2012US8287923 Compositions and methods for treating immune disorders
10/16/2012US8287877 Composition comprising immunogenic microparticles
10/16/2012US8287875 Nucleic acids encoding a house dust mite allergen, Der p III, and uses therefor
10/16/2012US8287866 Methods of treating IL-TIF associated inflammatory or immune diseases using antibodies against soluble zcytor 11 cytokine receptors
10/16/2012CA2634992C Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
10/16/2012CA2544155C Drug and method for proliferating natural killer cells
10/16/2012CA2533753C Drug for cancer therapy
10/16/2012CA2526884C P2x7 receptor antagonists and their use
10/16/2012CA2485794C Triptolide derivatives for modulation of apoptosis and immunosuppression
10/16/2012CA2485681C Ccr9 inhibitors and methods of use thereof
10/16/2012CA2480696C Peptide epitopes common to antigens of the same multigene family
10/16/2012CA2412498C Non-human animal models of tolerance to hepatitis c virus immunogenes
10/16/2012CA2404340C Methods of blocking tissue destruction by autoreactive t cells
10/16/2012CA2393904C Hepoxilin analogs
10/16/2012CA2356257C Insulin-like growth factor (igf) i mutant variants
10/16/2012CA2250970C Cyclosporin emulsions
10/16/2012CA2132873C Peptides useful for inducing tolerance
10/11/2012WO2012139081A2 Methods for treating conditions associated with masp-2 dependent complement activation
10/11/2012WO2012138797A1 3- or 5 - bi phenyl - 4 - ylisoxazole - based compounds useful for the treatment of fibrosis, pain, cancer and respiratory, allergic, nervous system or cardiovascular disorders
10/11/2012WO2012138294A1 Novel peptides that bind to types of mhc class ii and their use on diagnosis and treatment
10/11/2012WO2012136622A1 Dihydropyrrolo pyrimidine derivatives as mtor inhibitors
10/11/2012WO2012136543A1 Use of a hypoallergenic cereal composition for including specific oral tolerance
10/11/2012WO2012136224A2 Methods and compositions for enhancing pulmonary host defense in acute and chronic radiation syndrome, therapeutic radiation intervention and cancer therapy
10/11/2012WO2012136121A1 Amino phenylpropanoid compound and use thereof for preparing immunosuppressant
10/11/2012WO2012136120A1 Aryl acrylamide compound and use thereof in preparing immunosuppressant
10/11/2012WO2012136111A1 Phenylpropionic acid compound, preparation method therefor and medicinal use thereof
10/11/2012WO2012136110A1 Pharmaceutical formulation for treating allergic rhinitis and preparation method thereof
10/11/2012WO2012135959A1 Protease cleavage site peptides as an hiv vaccine
10/11/2012WO2012135951A1 Oral enzyme compositions for intestinal delivery
10/11/2012WO2012085603A3 Dna sensors
10/11/2012US20120259151 Pyridopyrazine derivatives and their use
10/11/2012US20120259095 Monoclonal antibodies with enhanced adcc function
10/11/2012US20120259093 Expression of secreted human alpha-fetoprotein in transgenic animals
10/11/2012US20120258996 Novel ligands that modulate rar receptors
10/11/2012US20120258987 Lysophosphatidic acid receptor antagonists
10/11/2012US20120258983 Pharmaceutical Composition and Administrations Thereof
10/11/2012US20120258981 Process for the Synthesis of Quaternary Amine Compounds
10/11/2012US20120258967 Pi3 kinase inhibitors and uses thereof
10/11/2012US20120258962 1,3-oxazines as bace1 and/or bace2 inhibitors
10/11/2012US20120258960 Novel multifunctional peptidase inhibitors, especially for medical use
10/11/2012US20120258958 Azaindoles useful as inhibitors of jak and other protein kinases
10/11/2012US20120258952 Substituted N-(1H-Indazol-4-yl)Imidazo[1,2-a]Pyridine-3-Carboxamide Compounds as cFMS Inhibitors
10/11/2012US20120258949 Spirocyclic derivatives as histone deacetylase inhibitors
10/11/2012US20120258938 Enzymatic Production or Chemical Synthesis and Uses for 5,7-Dienes and UVB Conversion Products Thereof
10/11/2012US20120258930 The Improvement of Gastrointestinal Health, Immunity and Performance by Dietary Intervention
10/11/2012US20120258927 Inhibitors of e1 activating enzymes
10/11/2012US20120258905 Vitamin receptor drug delivery conjugates for treating inflammation
10/11/2012US20120258169 Chewable Soft Capsule
10/11/2012US20120258162 Controlled delivery of molecules from a biointerface
10/11/2012US20120258147 Method for inhibiting angiogenesis
10/11/2012US20120258145 Adjuvant for vaccines, vaccines that comprise said adjuvant and uses thereof
10/11/2012US20120258144 SUPPRESSORS OF CpG OLIGONUCLEOTIDES AND METHODS OF USE
10/11/2012US20120258143 Pharmaceutical formulation and process comprising a solid dispersion of macrolide (tacrolimus)
10/11/2012US20120258142 Glycolipids and analogues thereof as antigens for nkt cells
10/11/2012US20120258141 Methods Of Immune Modulation
10/11/2012US20120258140 Rna sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles
10/11/2012US20120258139 Attenuated Live Vaccines for Aquatic Animals
10/11/2012US20120258136 Methods for cultivating cells, propagating and purifying viruses
10/11/2012US20120258135 Immunogenic anti-inflammatory compositions
10/11/2012US20120258134 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
10/11/2012US20120258133 Construct
10/11/2012US20120258129 Mycobacterium tuberculosis fusion protein and uses thereof
10/11/2012US20120258128 Infection Factor Assay
10/11/2012US20120258125 Method to identify a novel class of immunologic adjuvants
10/11/2012US20120258124 Antigen-antibody complexes as hiv-1 vaccines
10/11/2012US20120258114 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
10/11/2012US20120258111 Compositions and methods for modulating rsv infection and immunity
10/11/2012US20120258107 Agents, Uses and Methods
10/11/2012US20120258097 Methods of using btl-ii proteins
10/11/2012US20120258096 Anti-d monoclonal antibodies
10/11/2012US20120258095 Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
1 ... 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 ... 1172